Protein disorder in the human diseasome: unfoldomics of human genetic diseases

[1]  J. Neher.  A problem of multiple comparisons , 2011 .

[2]  Ferenc Orosz,et al.  Protein Folding and Misfolding: Neurodegenerative Diseases , 2009 .

[3]  Vladimir N Uversky,et al.  Intrinsic disorder in proteins associated with neurodegenerative diseases. , 2009, Frontiers in bioscience.

[4]  V. Uversky.  Alpha-synuclein misfolding and neurodegenerative diseases. , 2008, Current protein & peptide science.

[5]  A Keith Dunker,et al.  Intrinsic disorder in scaffold proteins: getting more from less. , 2008, Progress in biophysics and molecular biology.

[6]  Vladimir N Uversky,et al.  Amyloidogenesis of natively unfolded proteins. , 2008, Current Alzheimer research.

[7]  Albert H. Mao,et al.  Role of backbone-solvent interactions in determining conformational equilibria of intrinsically disordered proteins. , 2008, Journal of the American Chemical Society.

[8]  Christopher J. Oldfield,et al.  Intrinsically disordered proteins in human diseases: introducing the D2 concept. , 2008, Annual review of biophysics.

[9]  Christopher J. Oldfield,et al.  Flexible nets: disorder and induced fit in the associations of p53 and 14-3-3 with their partners , 2008, BMC Genomics.

[10]  I. McEwan,et al.  Structural characterization of the native NH2-terminal transactivation domain of the human androgen receptor: a collapsed disordered conformation underlies structural plasticity and protein-induced folding. , 2008, Biochemistry.

[11]  A Keith Dunker,et al.  Intrinsic disorder in pathogenic and non-pathogenic microbes: discovering and analyzing the unfoldomes of early-branching eukaryotes. , 2008, Molecular bioSystems.

[12]  K. Dill,et al.  The protein folding problem. , 1993, Annual review of biophysics.

[13]  Barry Robson,et al.  Protein folding revisited. , 2008, Progress in molecular biology and translational science.

[14]  A. Keith Dunker,et al.  Mining α-Helix-Forming Molecular Recognition Features with Cross Species Sequence Alignments† , 2007 .

[15]  G. Zambetti,et al.  The p53 mutation “gradient effect” and its clinical implications , 2007, Journal of cellular physiology.

[16]  Vladimir N. Uversky,et al.  Neuropathology, biochemistry, and biophysics of α‐synuclein aggregation , 2007 .

[17]  S. Cascio,et al.  Founder mutations in BRCA1 and BRCA2 genes. , 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

[18]  A. Barabasi,et al.  The human disease network , 2007, Proceedings of the National Academy of Sciences.

[19]  A Keith Dunker,et al.  Characterization of molecular recognition features, MoRFs, and their binding partners. , 2007, Journal of proteome research.

[20]  Jing Zhang,et al.  Identification of Novel Proteins Associated with Both α-Synuclein and DJ-1*S , 2007, Molecular & Cellular Proteomics.

[21]  Christopher J. Oldfield,et al.  Functional anthology of intrinsic disorder. 3. Ligands, post-translational modifications, and diseases associated with intrinsically disordered proteins. , 2007, Journal of proteome research.

[22]  A Keith Dunker,et al.  Functional anthology of intrinsic disorder. 2. Cellular components, domains, technical terms, developmental processes, and coding sequence diversities correlated with long disordered regions. , 2007, Journal of proteome research.

[23]  Christopher J. Oldfield,et al.  Functional anthology of intrinsic disorder. 1. Biological processes and functions of proteins with long disordered regions. , 2007, Journal of proteome research.

[24]  Vladislav Yu Orekhov,et al.  Binding of intrinsically disordered proteins is not necessarily accompanied by a structural transition to a folded form. , 2007, Biochimie.

[25]  Christopher J. Oldfield,et al.  Intrinsic disorder and functional proteomics. , 2007, Biophysical journal.

[26]  Zoran Obradovic,et al.  DisProt: the Database of Disordered Proteins , 2006, Nucleic Acids Res..

[27]  Vladimir N Uversky,et al.  Neuropathology, biochemistry, and biophysics of alpha-synuclein aggregation. , 2007, Journal of neurochemistry.

[28]  V. Uversky,et al.  Lipid-binding activity of intrinsically unstructured cytoplasmic domains of multichain immune recognition receptor signaling subunits. , 2006, Biochemistry.

[29]  Ronald Wetzel,et al.  Fluorescence correlation spectroscopy shows that monomeric polyglutamine molecules form collapsed structures in aqueous solutions , 2006, Proceedings of the National Academy of Sciences.

[30]  Marc S. Cortese,et al.  Analysis of molecular recognition features (MoRFs). , 2006, Journal of molecular biology.

[31]  A. Dunker,et al.  Disorder and sequence repeats in hub proteins and their implications for network evolution. , 2006, Journal of proteome research.

[32]  A. Sigalov.  Immune cell signaling: a novel mechanistic model reveals new therapeutic targets. , 2006, Trends in pharmacological sciences.

[33]  Sonia Longhi,et al.  A practical overview of protein disorder prediction methods , 2006, Proteins.

[34]  A. Dunker,et al.  Abundance of intrinsic disorder in protein associated with cardiovascular disease. , 2006, Biochemistry.

[35]  Lilia M. Iakoucheva,et al.  Intrinsic Disorder Is a Common Feature of Hub Proteins from Four Eukaryotic Interactomes , 2006, PLoS Comput. Biol..

[36]  A. Elofsson,et al.  What properties characterize the hub proteins of the protein-protein interaction network of Saccharomyces cerevisiae? , 2006, Genome Biology.

[37]  A Keith Dunker,et al.  Alternative splicing in concert with protein intrinsic disorder enables increased functional diversity in multicellular organisms. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[38]  A. Barabasi,et al.  A Protein–Protein Interaction Network for Human Inherited Ataxias and Disorders of Purkinje Cell Degeneration , 2006, Cell.

[39]  A Keith Dunker,et al.  Calmodulin signaling: Analysis and prediction of a disorder‐dependent molecular recognition , 2006, Proteins.

[40]  Haruki Nakamura,et al.  Disordered domains and high surface charge confer hubs with the ability to interact with multiple proteins in interaction networks , 2006, FEBS letters.

[41]  Debasis Dash,et al.  Intrinsic unstructuredness and abundance of PEST motifs in eukaryotic proteomes , 2005, Proteins.

[42]  Zoran Obradovic,et al.  Length-dependent prediction of protein intrinsic disorder , 2006, BMC Bioinformatics.

[43]  S. L. Wong,et al.  Towards a proteome-scale map of the human protein–protein interaction network , 2005, Nature.

[44]  Marc S. Cortese,et al.  Flexible nets , 2005, The FEBS journal.

[45]  H. Lehrach,et al.  A Human Protein-Protein Interaction Network: A Resource for Annotating the Proteome , 2005, Cell.

[46]  Christopher J. Oldfield,et al.  Showing your ID: intrinsic disorder as an ID for recognition, regulation and cell signaling , 2005, Journal of molecular recognition : JMR.

[47]  Marc S. Cortese,et al.  Coupled folding and binding with α-helix-forming molecular recognition elements , 2005 .

[48]  Zsuzsanna Dosztányi,et al.  IUPred: web server for the prediction of intrinsically unstructured regions of proteins based on estimated energy content , 2005, Bioinform..

[49]  Christopher J. Oldfield,et al.  Addressing the intrinsic disorder bottleneck in structural proteomics , 2005, Proteins.

[50]  A. Üren,et al.  PTPL1 is a direct transcriptional target of EWS-FLI1 and modulates Ewing's Sarcoma tumorigenesis , 2005, Oncogene.

[51]  H. Dyson,et al.  Intrinsically unstructured proteins and their functions , 2005, Nature Reviews Molecular Cell Biology.

[52]  Marc S. Cortese,et al.  Comparing and combining predictors of mostly disordered proteins. , 2005, Biochemistry.

[53]  Cheryl H Arrowsmith,et al.  Characterization of segments from the central region of BRCA1: an intrinsically disordered scaffold for multiple protein-protein and protein-DNA interactions? , 2005, Journal of molecular biology.

[54]  Marc S. Cortese,et al.  Coupled folding and binding with alpha-helix-forming molecular recognition elements. , 2005, Biochemistry.

[55]  A. Sigalov.  Multichain immune recognition receptor signaling: different players, same game? , 2004, Trends in immunology.

[56]  J. Toretsky,et al.  Recombinant EWS-FLI1 oncoprotein activates transcription. , 2004, Biochemistry.

[57]  David W. Miller,et al.  α-Synuclein in blood and brain from familial Parkinson disease with SNCA locus triplication , 2004, Neurology.

[58]  A. Singleton,et al.  Association between cardiac denervation and parkinsonism caused by α‐synuclein gene triplication , 2004 .

[59]  J. S. Sodhi,et al.  Prediction and functional analysis of native disorder in proteins from the three kingdoms of life. , 2004, Journal of molecular biology.

[60]  Matthew J. Farrer,et al.  Comparison of kindreds with parkinsonism and α‐synuclein genomic multiplications , 2004 .

[61]  J. Hoenicka,et al.  The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia , 2004, Annals of neurology.

[62]  A. Sigalov,et al.  Homooligomerization of the cytoplasmic domain of the T cell receptor zeta chain and of other proteins containing the immunoreceptor tyrosine-based activation motif. , 2004, Biochemistry.

[63]  E. Dennis,et al.  Handbook of cell signaling , 2004 .

[64]  M. Farrer,et al.  Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications. , 2004, Annals of neurology.

[65]  A Keith Dunker,et al.  Natively Disordered Proteins , 2004, Applied bioinformatics.

[66]  A. Singleton,et al.  Association between cardiac denervation and parkinsonism caused by alpha-synuclein gene triplication. , 2004, Brain : a journal of neurology.

[67]  Janel O. Johnson,et al.  α-Synuclein Locus Triplication Causes Parkinson's Disease , 2003, Science.

[68]  Johannes Buchner,et al.  The N-terminal domain of p53 is natively unfolded. , 2003, Journal of molecular biology.

[69]  Vladimir N Uversky,et al.  A Protein-Chameleon: Conformational Plasticity of α-Synuclein, a Disordered Protein Involved in Neurodegenerative Disorders , 2003, Journal of biomolecular structure & dynamics.

[70]  V. Uversky,et al.  Protein folding revisited. A polypeptide chain at the folding – misfolding – nonfolding cross-roads: which way to go? , 2003, Cellular and Molecular Life Sciences CMLS.

[71]  E. Oláh,et al.  Emerging roles of BRCA1 alternative splicing , 2003, Molecular pathology : MP.

[72]  V. Buchman,et al.  Part II: α-synuclein and its molecular pathophysiological role in neurodegenerative disease , 2003, Neuropharmacology.

[73]  J. Trojanowski,et al.  Parkinson's Disease and Related α‐Synucleinopathies Are Brain Amyloidoses , 2003, Annals of the New York Academy of Sciences.

[74]  S. Welford,et al.  PIM3 Proto-Oncogene Kinase Is a Common Transcriptional Target of Divergent EWS/ETS Oncoproteins , 2003, Molecular and Cellular Biology.

[75]  Y. Iwamoto,et al.  Identification of p21 WAF1/CIP1 as a Direct Target of EWS-Fli1 Oncogenic Fusion Protein* , 2003, The Journal of Biological Chemistry.

[76]  Yusuke Nakamura,et al.  Induction of tenascin‐C by tumor‐specific EWS‐ETS fusion genes , 2003, Genes, chromosomes & cancer.

[77]  E. Appella,et al.  CHAPTER 306 – Signaling to the p53 Tumor Suppressor through Pathways Activated by Genotoxic and Nongenotoxic Stresses , 2003 .

[78]  V. Buchman,et al.  Part II: alpha-synuclein and its molecular pathophysiological role in neurodegenerative disease. , 2003, Neuropharmacology.

[79]  A. Singleton,et al.  alpha-Synuclein locus triplication causes Parkinson's disease. , 2003, Science.

[80]  E. Oláh,et al.  Emerging roles of BRCA1 alternative splicing , 2003, Molecular pathology : MP.

[81]  Yusuke Nakamura,et al.  The Id2 gene is a novel target of transcriptional activation by EWS-ETS fusion proteins in Ewing family tumors , 2002, Oncogene.

[82]  L. Iakoucheva,et al.  Intrinsic disorder in cell-signaling and cancer-associated proteins. , 2002, Journal of molecular biology.

[83]  P. Tompa.  Intrinsically unstructured proteins. , 2002, Trends in biochemical sciences.

[84]  Xin Lu,et al.  Live or let die: the cell's response to p53 , 2002, Nature Reviews Cancer.

[85]  E. Appella,et al.  SIGNALING TO THE P53 TUMOR SUPPRESSOR THROUGH PATHWAYS ACTIVATED BY GENOTOXIC AND NON-GENOTOXIC STRESSES. , 2002 .

[86]  Ronald Wetzel,et al.  Amyloid-like features of polyglutamine aggregates and their assembly kinetics. , 2002, Biochemistry.

[87]  M. Perutz,et al.  Aggregation of proteins with expanded glutamine and alanine repeats of the glutamine-rich and asparagine-rich domains of Sup35 and of the amyloid β-peptide of amyloid plaques , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[88]  V. Uversky.  Natively unfolded proteins: A point where biology waits for physics , 2002, Protein science : a publication of the Protein Society.

[89]  H. Dyson,et al.  Coupling of folding and binding for unstructured proteins. , 2002, Current opinion in structural biology.

[90]  A Keith Dunker,et al.  Intrinsic disorder and protein function. , 2002, Biochemistry.

[91]  Zoran Obradovic,et al.  The protein trinity—linking function and disorder , 2001, Nature Biotechnology.

[92]  R. Wetzel,et al.  Polyglutamine aggregation behavior in vitro supports a recruitment mechanism of cytotoxicity. , 2001, Journal of molecular biology.

[93]  D. Dickson,et al.  Alpha-synuclein and the Lewy body disorders. , 2001, Current opinion in neurology.

[94]  Y. Benjamini,et al.  THE CONTROL OF THE FALSE DISCOVERY RATE IN MULTIPLE TESTING UNDER DEPENDENCY , 2001 .

[95]  Michel Goedert,et al.  Alpha-synuclein and neurodegenerative diseases , 2001, Nature Reviews Neuroscience.

[96]  S. Baker,et al.  EWS/FLI Alters 5′-Splice Site Selection* , 2001, The Journal of Biological Chemistry.

[97]  O. Delattre,et al.  Analysis of the expression of cell cycle regulators in Ewing cell lines: EWS-FLI-1 modulates p57KIP2 and c-Myc expression , 2001, Oncogene.

[98]  K. Fischbeck,et al.  Polyglutamine and CBP: Fatal attraction? , 2001, Nature Medicine.

[99]  Michel Goedert,et al.  Parkinsons Disease and other α-Synucleinopathies , 2001 .

[100]  Leena Peltonen,et al.  Dissecting Human Disease in the Postgenomic Era , 2001, Science.

[101]  David Valle,et al.  Human disease genes , 2001, Nature.

[102]  J Q Trojanowski,et al.  Synucleinopathies: clinical and pathological implications. , 2001, Archives of neurology.

[103]  W. May,et al.  PDGF-C is an EWS/FLI induced transforming growth factor in Ewing family tumors , 2001, Oncogene.

[104]  Zoran Obradovic,et al.  The Protein Non-Folding Problem: Amino Acid Determinants of Intrinsic Order and Disorder , 2000, Pacific Symposium on Biocomputing.

[105]  Christopher J. Oldfield,et al.  Intrinsically disordered protein. , 2001, Journal of molecular graphics & modelling.

[106]  V A McKusick,et al.  Genomics and medicine. Dissecting human disease in the postgenomic era. , 2001, Science.

[107]  M. Goedert.  Parkinson's disease and other alpha-synucleinopathies. , 2001, Clinical chemistry and laboratory medicine.

[108]  P. Romero,et al.  Sequence complexity of disordered protein , 2001, Proteins.

[109]  M. Goedert,et al.  The α‐Synucleinopathies: Parkinson's Disease, Dementia with Lewy Bodies, and Multiple System Atrophy , 2000 .

[110]  A. Levine,et al.  Surfing the p53 network , 2000, Nature.

[111]  V. Uversky,et al.  Why are “natively unfolded” proteins unstructured under physiologic conditions? , 2000, Proteins.

[112]  Kyou-Hoon Han,et al.  Local Structural Elements in the Mostly Unstructured Transcriptional Activation Domain of Human p53* , 2000, The Journal of Biological Chemistry.

[113]  E. Wanker.  Protein Aggregation and Pathogenesis of Huntingtons Disease: Mechanisms and Correlations , 2000, Biological chemistry.

[114]  K. Fischbeck,et al.  CREB-binding protein sequestration by expanded polyglutamine. , 2000, Human molecular genetics.

[115]  M. Gerstein,et al.  Proteomics of Mycoplasma genitalium: identification and characterization of unannotated and atypical proteins in a small model genome. , 2000, Nucleic acids research.

[116]  S. Baker,et al.  The Splicing Factor U1C Represses EWS/FLI-mediated Transactivation* , 2000, The Journal of Biological Chemistry.

[117]  C. Deng,et al.  Roles of BRCA1 and its interacting proteins , 2000, BioEssays : news and reviews in molecular, cellular and developmental biology.

[118]  D. Housman,et al.  The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[119]  D. Notterman,et al.  Analysis of p53-regulated gene expression patterns using oligonucleotide arrays. , 2000, Genes & development.

[120]  M. Goedert,et al.  The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy. , 2000, Annals of the New York Academy of Sciences.

[121]  M. Hollstein,et al.  p53 and human cancer: the first ten thousand mutations. , 2000, Advances in cancer research.

[122]  J. Levine,et al.  Surfing the p53 network , 2000, Nature.

[123]  C. Brown,et al.  Intrinsic protein disorder in complete genomes. , 2000, Genome informatics. Workshop on Genome Informatics.

[124]  P. Sorensen,et al.  Delayed early embryonic lethality following disruption of the murine cyclin A2 gene , 1999, Nature Genetics.

[125]  H. Dyson,et al.  Intrinsically unstructured proteins: re-assessing the protein structure-function paradigm. , 1999, Journal of molecular biology.

[126]  H. Zoghbi,et al.  Polyglutamine diseases: protein cleavage and aggregation , 1999, Current Opinion in Neurobiology.

[127]  P. Sorensen,et al.  Delayed early embryonic lethality following disruption of the murine cyclin A2 gene , 1999, Nature Genetics.

[128]  J. M. Boutell,et al.  Aberrant interactions of transcriptional repressor proteins with the Huntington's disease gene product, huntingtin. , 1999, Human molecular genetics.

[129]  M. Goedert.  Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies. , 1999, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[130]  D. Housman,et al.  Evidence for a recruitment and sequestration mechanism in Huntington's disease. , 1999, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[131]  D. Borchelt,et al.  Polyglutamine pathogenesis. , 1999, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[132]  Obradovic,et al.  Predicting Binding Regions within Disordered Proteins. , 1999, Genome informatics. Workshop on Genome Informatics.

[133]  S. Welford,et al.  EWS/FLI1 up regulates mE2-C, a cyclin-selective ubiquitin conjugating enzyme involved in cyclin B destruction , 1998, Oncogene.

[134]  M. MacDonald,et al.  Huntingtin interacts with a family of WW domain proteins. , 1998, Human molecular genetics.

[135]  R. Krüger,et al.  Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. , 1998, Nature genetics.

[136]  A K Dunker,et al.  Protein disorder and the evolution of molecular recognition: theory, predictions and observations. , 1998, Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing.

[137]  A K Dunker,et al.  Thousands of proteins likely to have long disordered regions. , 1998, Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing.

[138]  Marcienne M Wright,et al.  EWS/FLI1-induced manic fringe renders NIH 3T3 cells tumorigenic , 1997, Nature Genetics.

[139]  Robert L. Nussbaum,et al.  Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .

[140]  A.K. Dunker,et al.  Identifying disordered regions in proteins from amino acid sequence , 1997, Proceedings of International Conference on Neural Networks (ICNN'97).

[141]  C. Denny,et al.  EAT-2 is a novel SH2 domain containing protein that is up regulated by Ewing's sarcoma EWS/FLI1 fusion gene. , 1996, Oncogene.

[142]  M. Perutz,et al.  Glutamine repeats and inherited neurodegenerative diseases: molecular aspects. , 1996, Current opinion in structural biology.

[143]  P. Lansbury,et al.  NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded. , 1996, Biochemistry.

[144]  J. M. Boyd,et al.  Molecular cloning and characterization of a cellular phosphoprotein that interacts with a conserved C-terminal domain of adenovirus E1A involved in negative modulation of oncogenic transformation. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[145]  M. King,et al.  Inherited breast and ovarian cancer. , 1995, Human molecular genetics.

[146]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[147]  E. Mandelkow,et al.  Structural studies of tau protein and Alzheimer paired helical filaments show no evidence for beta-structure. , 1994, The Journal of biological chemistry.

[148]  M. Roussel,et al.  DNA-binding and transcriptional activation properties of the EWS-FLI-1 fusion protein resulting from the t(11;22) translocation in Ewing sarcoma , 1994, Molecular and cellular biology.

[149]  J. Epstein,et al.  Identification of a Pax paired domain recognition sequence and evidence for DNA-dependent conformational changes. , 1994, The Journal of biological chemistry.

[150]  C. Denny,et al.  Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLI1 for transformation. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[151]  G. Thomas,et al.  Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours , 1992, Nature.

[152]  B. Vogelstein,et al.  p53 mutations in human cancers. , 1991, Science.

[153]  M. DePamphilis,et al.  HUMAN DISEASE , 1957, The Ulster Medical Journal.

[154]  Clyde Young Kramer,et al.  Extension of multiple range tests to group means with unequal numbers of replications , 1956 .

[155]  H. B. Mann,et al.  On a Test of Whether one of Two Random Variables is Stochastically Larger than the Other , 1947 .

[156]  F. Wilcoxon.  Individual Comparisons by Ranking Methods , 1945 .